🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.05
-0.07 (-0.98%)
Nov 20, 2026, 4:00 PM EST - Market closed

Puma Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
41.5529.6469.2284.5976.263.13
Short-Term Investments
67.0367.8931.7511.354.8718.98
Cash & Short-Term Investments
108.5897.53100.9795.9481.0782.11
Cash Growth
15.03%-3.40%5.24%18.34%-1.26%-12.08%
Accounts Receivable
32.8353.6532.0147.8440.3532.53
Other Receivables
----1.92-
Receivables
32.8353.6532.0147.8442.2732.53
Inventory
11.495.528.727.084.537.11
Prepaid Expenses
1.691.631.832.482.628.98
Restricted Cash
-2.09---8.85
Other Current Assets
3.052.274.132.853.790.45
Total Current Assets
157.63162.69147.66156.19134.28140.02
Property, Plant & Equipment
4.355.565.098.6512.5115.77
Other Intangible Assets
34.0941.3951.1360.8770.6166.13
Long-Term Deferred Tax Assets
3.833.837.08---
Long-Term Deferred Charges
0.10.10.10.21-0.58
Other Long-Term Assets
2.772.732.274.624.664.09
Total Assets
202.77216.3213.33230.53222.06226.59

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.065.065.516.896.4411.17
Accrued Expenses
30.435.8226.0735.6332.7324.03
Current Portion of Long-Term Debt
-22.5245.3334--
Current Portion of Leases
0.681.315.544.84.143.57
Other Current Liabilities
15.8316.5413.6618.0734.1770.81
Total Current Liabilities
51.9781.2596.1199.3877.48109.59
Long-Term Debt
--21.7265.6698.3197.09
Long-Term Leases
4.184.711.497.0311.8315.98
Other Long-Term Liabilities
--1.885.0112.836.38
Total Liabilities
56.1585.96121.21177.09200.45229.03

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010
Additional Paid-In Capital
1,4201,4141,4071,3991,3881,364
Retained Earnings
-1,273-1,284-1,315-1,345-1,367-1,367
Comprehensive Income & Other
-0.10.040.01-0--0
Shareholders' Equity
146.61130.3492.1353.4421.61-2.45
Total Liabilities & Equity
202.77216.3213.33230.53222.06226.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4.8728.5574.08111.49114.28116.64
Net Cash (Debt)
103.7168.9826.88-15.55-33.21-34.54
Net Cash Growth
94.45%156.60%----
Net Cash Per Share
1.981.360.55-0.33-0.74-0.85
Filing Date Shares Outstanding
51.750.8849.6148.2146.6441.33
Total Common Shares Outstanding
51.6950.4149.1147.6546.3541.18
Working Capital
105.6681.4351.5556.856.830.44
Book Value Per Share
2.842.591.881.120.47-0.06
Tangible Book Value
112.5388.9540.99-7.43-49-68.57
Tangible Book Value Per Share
2.181.760.83-0.16-1.06-1.67
Machinery
1.322.244.64.764.794.84
Leasehold Improvements
1.72.553.783.783.783.78
SEC Filings: 10-K · 10-Q